Metrics in Patient-Centered Drug Development Conference

There is growing consensus among stakeholders in the medical product life cycle that patient engagement is critical to assuring that patient needs -- including those associated with clinical trial participation and with patient outcomes, are met. The moral, ethical, and pragmatic reasons for patient engagement are widely accepted, but research sponsors are also looking to understand the impact of patient engagement on study timelines and costs and on overall program success. Understanding return on investment, or return on engagement (ROE), is complicated by the availability of many different types of patient engagement efforts that could be employed and the lack of information about their value in a given context.

Presenters in this session will discuss the results of recent retrospective and prospective studies quantifying the return on patient engagement. This session will also explore the importance of establishing consensus metrics to measure and benchmark ROE.